We are delighted to share that Dr. Peter Teo recently served as the chairperson and host for a dinner symposium titled “Emerging Approaches in ER+ HER2- Metastatic Breast Cancer Management.” This impactful event was co-organized by the Hong Kong Society of Clinical Oncology, Menarini Group, and its subsidiary Stemline Therapeutics Inc. The symposium brought together local and international experts to explore the latest advancements in the treatment of ER+ HER2- metastatic breast cancer.

The symposium highlighted how innovative treatment strategies are providing patients with renewed hope and improved outcomes. Renowned international speakers, including Prof. Giuseppe Curigliano, Dr. Lee Chern Siang, Prof. Lee Soo Chin, and Prof. Winnie Yeo, shared cutting-edge research findings and practical insights on applying these advancements in clinical practice to enhance patient care and quality of life.

Dr. Teo moderated multiple Q&A sessions and led roundtable discussions, fostering deeper understanding among attendees on optimizing treatment strategies and delivering better care solutions for patients.